Are you Dr. Aisner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Summary
- Dr. Dara Aisner, MD is a board certified pathologist in Aurora, Colorado. She is currently licensed to practice medicine in Colorado, Pennsylvania, and Maryland. She is affiliated with University of Colorado Hospital and UCHealth Memorial Hospital.
Education & Training
University of Pennsylvania Health SystemFellowship, Molecular Genetic Pathology, 2009 - 2010
National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2004 - 2008
University of Texas Southwestern Medical SchoolClass of 2004
Certifications & Licensure
CO State Medical License 2010 - 2025
MD State Medical License 2006 - 2010
PA State Medical License 2008 - 2010- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Clinical Informatics
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 44 citationsPediatric Brainstem Gangliogliomas Show BRAFV600E Mutation in a High Percentage of CasesAndrew M. Donson, Bette K. Kleinschmidt-DeMasters, Dara L. Aisner, Lynne T. Bemis, Diane Birks
Brain Pathology. 2014-03-01 - 617 citationsNon-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica R Bauman
Journal of the National Comprehensive Cancer Network. 2022-05-01 - 97 citationsRapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmo...Deepali Jain, Timothy Craig Allen, Dara L. Aisner, Mary Beth Beasley, Philip T. Cagle
Archives of Pathology & Laboratory Medicine. 2017-06-22
Authored Content
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase InhibitorsJanuary 2018
Press Mentions
Pursuing Precision Oncology with World-Class Custom Bioinformatic PipelinesSeptember 23rd, 2024- CU Anschutz Researchers Roll Out Antibody TestJune 9th, 2020
- CU Cell Technologies Shared Resource Makes COVID-19 Proteins for Research, Antibody TestingMay 29th, 2020
- Join now to see all
Professional Memberships
- Member
